Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
27.74
Dollar change
+1.75
Percentage change
6.73
%
IndexRUT P/E- EPS (ttm)- Insider Own37.08% Shs Outstand83.47M Perf Week-7.13%
Market Cap2.36B Forward P/E- EPS next Y- Insider Trans-5.87% Shs Float53.58M Perf Month-14.86%
Enterprise Value2.09B PEG- EPS next Q-0.17 Inst Own42.36% Short Float6.49% Perf Quarter-20.08%
Income- P/S- EPS this Y- Inst Trans90.36% Short Ratio3.74 Perf Half Y-
Sales- P/B9.10 EPS next Y- ROA- Short Interest3.48M Perf YTD-4.84%
Book/sh3.05 P/C8.11 EPS next 5Y- ROE- 52W High41.22 -32.71% Perf Year-
Cash/sh3.42 P/FCF- EPS past 3/5Y- - ROIC- 52W Low25.38 9.30% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility8.78% 7.13% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)2.17 Perf 10Y-
Dividend Ex-Date- Quick Ratio8.60 Sales Y/Y TTM- Profit Margin- RSI (14)39.37 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio8.60 EPS Q/Q- SMA20-12.18% Beta- Target Price38.50
Payout- Debt/Eq0.09 Sales Q/Q- SMA50-8.49% Rel Volume3.14 Prev Close25.99
Employees- LT Debt/Eq0.06 EarningsNov 12 AMC SMA200-13.44% Avg Volume930.27K Price27.74
IPOAug 08, 2025 Option/ShortYes / Yes EPS/Sales Surpr.-11.39% 10.10% Trades Volume2,917,962 Change6.73%
Date Action Analyst Rating Change Price Target Change
Jan-28-26Initiated Wells Fargo Overweight $38
Sep-02-25Initiated Stifel Buy $35
Sep-02-25Initiated Piper Sandler Overweight $38
Sep-02-25Initiated Morgan Stanley Equal-Weight $35
Sep-02-25Initiated JP Morgan Overweight $36
Sep-02-25Initiated Canaccord Genuity Buy $35
Jan-29-26 09:41AM
Jan-28-26 09:39AM
Jan-06-26 08:00AM
Jan-05-26 04:05PM
Dec-23-25 11:53PM
07:42PM Loading…
Dec-18-25 07:42PM
04:05PM
Dec-12-25 09:49AM
Dec-11-25 03:10AM
Nov-19-25 04:33PM
Nov-12-25 04:22PM
04:01PM
Nov-09-25 01:30PM
Nov-04-25 07:06AM
Nov-03-25 08:00AM
04:05PM Loading…
Oct-23-25 04:05PM
Oct-22-25 08:00AM
Sep-29-25 08:07AM
Sep-23-25 06:55PM
Sep-22-25 04:05PM
Sep-19-25 05:28PM
Sep-11-25 01:00AM
Sep-06-25 06:35AM
Sep-04-25 10:20AM
Sep-03-25 04:54PM
04:54PM
09:16AM
Sep-02-25 09:45AM
Aug-27-25 04:24PM
Aug-18-25 01:16PM
04:30PM Loading…
Aug-11-25 04:30PM
Aug-09-25 09:53AM
Aug-08-25 01:40PM
Jul-22-25 06:28PM
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cullivan Julie ADirectorFeb 05 '26Sale27.328,000218,56036,413Feb 06 09:42 PM
Bain Capital Life Sciences Inv10% OwnerFeb 04 '26Sale28.052,000,00056,100,00010,448,158Feb 06 04:58 PM
Cullivan Julie ADirectorFeb 05 '26Proposed Sale27.328,000218,560Feb 05 09:58 AM
Lightcap Jeffrey CDirectorDec 16 '25Buy26.3440,0001,053,68040,000Dec 17 06:43 PM